Medical Sciences celebrates success at Vice-Chancellor’s Awards 2024
10 May 2024
Awards and Appointments General
The Vice-Chancellor Professor Irene Tracey, CBE FRS FMedSci, presented the awards at a special ceremony at the Sheldonian Theatre.
New study from the Akerman group reveals the developmental origins of higher-order thalamocortical circuits in the brain
10 May 2024
A new paper by the Akerman Group is published in the journal Cell Reports this week and reveals how fine scale synaptic connectivity in the adult brain is shaped by events during embryonic development.
Our new vaccine could protect against coronaviruses that haven’t even emerged yet – new study
8 May 2024
The rapid development of vaccines that protect against COVID was a remarkable scientific achievement that saved millions of lives.
Ground-breaking study reveals how COVID-19 vaccines prevent severe disease
7 May 2024
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
Novel triple drug combination effective against antibiotic-resistant bacteria
7 May 2024
Scientists at the Ineos Oxford Institute (IOI) have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance. The findings have been published in the journal Engineering.
Reflecting on Cyber Success – Protecting the Covid Vaccine
3 May 2024
In April, the Information Security Office invited the National Cyber Security Centre to Oxford to thank them for the work they did that kept Oxford’s vaccine research secure.
Researchers discover how immune cells hunt down cancer around the body
3 May 2024
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours - including when cancer has spread to a different part of the body.
Dr Ashwin Jainarayanan selected for 2024 Schmidt Science Fellow program
1 May 2024
Awards and Appointments General
Dr Ashwin Jainarayanan has been selected to become a 2024 Schmidt Science Fellow – an honour bestowed on only 32 exceptional early career researchers worldwide. The 2024 Fellows, nominated by 26 of the world’s leading institutions across North America, Europe, and Asia, were chosen for their potential to drive sector-wide change by pursuing ambitious interdisciplinary science projects.
New study sheds light on the debate surrounding two types of shoulder replacement surgery for osteoarthritis
1 May 2024
A new study has provided valuable insights into the ongoing debate surrounding two types of shoulder replacement surgery: reverse total shoulder replacement and anatomical total shoulder replacement as a treatment for patients with osteoarthritis.
Unveiling of Medawar Nobel Prize medal
30 April 2024
Awards and Appointments General
The Oxford immunology community celebrated the donation of Sir Peter Medawar’s Nobel Prize medal to the University.
Immunology at the MRC WIMM
29 April 2024
For International Day of Immunology 2024, three scientists from the MRC Translational Immune Discovery Unit speak about their research.
R21 anti-malaria vaccine is a game changer
29 April 2024
Scientist who helped design it reflects on 30 years of research, and what it promises. Adrian Hill, director of the Jenner Institute at the University of Oxford and Chief Investigator for the R21 vaccine, tells Nadine Dreyer why he thinks this is a great era for malaria control.
Professor Mina Fazel appointed Chair of Child and Adolescent Psychiatry
18 April 2024
Awards and Appointments General
She will lead the Child and Adolescent Psychiatry research group, aiming to better understand how to prevent mental health difficulties in children and young people and how best to support them and their families
New heart disease calculator could save lives by identifying high-risk patients missed by current tools
18 April 2024
Collaborative research, led by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.
Celebrating innovation: the PRINCIPLE-PANORAMIC Celebratory Symposium and art exhibition
17 April 2024
Clinical Trials Events General Research
Researchers, clinicians, supporters and PPI contributors gathered at the symposium to celebrate the innovative PRINCIPLE and PANORAMIC clinical trials that evaluated potential treatments for COVID-19 during the pandemic and broke recruitment records for community-based trials in doing so. Both trials were run by the Clinical Trails Unit (CTU) in Nuffield Department of Primary Care Health Sciences.
New trial using skin patches as an ‘early warning system’ to spot lung transplant rejection
17 April 2024
A new trial, SENTINEL, is set to investigate if skin patches can be used as an early warning system to identify if lung transplants are being rejected, so treatment can begin sooner, reducing the chance of longer lasting organ damage.
Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine
16 April 2024
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.
Breakthrough aerosol human infection model gives hope for future tuberculosis vaccine development
16 April 2024
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs – the way TB enters the body.
Study challenges conventional understanding of household air pollution's impact on fetal growth
15 April 2024
In a ground-breaking study published today in Lancet Global Health, researchers present findings challenging conventional wisdom regarding the impact of household air pollution on fetal growth. The study, conducted in 3200 households across resource-poor settings in Guatemala, India, Rwanda, and Peru, focused on assessing the effects of reducing personal exposures to household air pollution on fetal growth in a randomized controlled trial.